Elanco Animal Health (ELAN): UBS Confident of 'Catalyst-Rich Story in 2026'
Tweet Send to a Friend
UBS analyst Andrea Alfonso reiterated a Buy rating and $31.00 price target on Elanco Animal Health (NYSE: ELAN).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
